Araccel Corporation Recognized as Number 1 in Frost & Sullivan: US Electronic Clinical Trials Market 2001.Business Editors/Health, Medical & High Tech Writers HORSHAM Horsham (hôr`shəm), town (1991 pop. 38,356) and district, West Sussex, SE England. Horsham is known primarily for its agricultural and merchandising activities, but it also serves as an engineering center. , Pa.--(BUSINESS WIRE)--Oct. 9, 2001 Araccel Corporation announced today that they have received the No. 1 ranking in the prestigious Frost & Sullivan, US Electronic Clinical Trials Market 2001 Report. Araccel was ranked No. 1 in Electronic Patient Diaries A Patient Diary is a tool used during a clinical trial or a disease treatment to measure treatment compliance. An Electronic Patient Diary registers the diary in a storage device and allows for monitoring the time the medication was taken. and No. 3 in Electronic Data Capture. Mr. Viswanathan Viswanathan is a surname and given name, and may refer to:
"With very little outstanding debt and access to cash float through their public trading status in Sweden, Araccel is probably one of the most attractive companies in which to invest. They are currently well above the 5x standard for scrutiny by most late stage venture investors, and may be in a position to significantly expand their large pharmaceutical customer base within the next year," said Amith Viswanathan, Frost & Sullivan Research Analyst and Author of Frost and Sullivan: US Electronic Clinical Trials Market 2001. "What makes Araccel a standout is that they have grown steadily from their years before the MiniDoc/Technologix merger, with top brandshare and marketshare already being transferred from the ex-MiniDoc EPD EPD expected progeny difference. system to their Evolution product," he added. "I am very pleased with the ranking of the Frost & Sullivan Report. This is confirmation of our focus on customers and the modular, flexible and scalable features of our technology platform. This ranking is a sound endorsement of all the great people at Araccel who contributed to this evaluation," said Jim Conklin, MD, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Araccel Corporation. About Araccel Corporation Araccel Corporation is the U.S. subsidiary of Araccel AB (ARAC B), a Swedish company that is publicly traded on the Nordic Growth Market (NGM See NetWare Global Messaging. ). Araccel AB is a global biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. information technology platform company that provides clinical informatics Clinical Informatics is a sub-field of medical informatics. It focuses on computer applications that address medical data (collection, analysis, representation). Clinical informatics is a combination of information science, computer science, and clinical science designed to assist solutions to the pharmaceutical industry to accelerate drug development. The company develops and markets electronic research and development (e-R&D) pharmaceutical software and system solutions that captures, analyzes and seamlessly integrates silos of data in order to decrease time and cost of development. Araccel Corporation is the market leader in its area and has 15 of the 20 largest pharmaceutical companies on its customer list. Araccel Corporation is headquartered in Horsham, PA. The Araccel Group also has operations in the UK, and The Netherlands. Araccel AB has approximately 2,900 stockholders and is quoted on the NGM Equity list in Stockholm. Stocks are traded via D. Carnegie AB. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion